Author

SHARON BREED

Institutions: University of Vienna, Mayo Clinic, Thomas Jefferson University, Emory University, Bostwick Laboratories, GlaxoSmithKline (United States)

Observed institutions: University of Vienna, Mayo Clinic, Thomas Jefferson University, Emory University, Bostwick Laboratories, GlaxoSmithKline (United States)

OpenAlex ID: A5033855666

Chemoprevention of Prostate Cancer in Men at High Risk: Rationale and Design of the Reduction by Dutasteride of Prostate Cancer Events (reduce) Trial

2004 · GERALD ANDRIOLE, DAVID BOSTWICK, et al. · The Journal of Urology · 291

Works count: 1

Citation count: 291

H-index: 1

I10-index: 1